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ABSTRACT
Objective: Evidence from randomised controlled trials
suggests that vitamin D may reduce multimorbidity,
but very few studies have investigated specific
determinants of vitamin D2 and D3 (two isoforms of
25-hydroxyvitamin D). The aim of the study was to
investigate the determinants of vitamin D2 and D3 and
to identify the risk factors associated with
hypovitaminosis D.
Design: Cross-sectional study.
Setting: Northern Finland Birth Cohort 1966.
Participants: 2374 male and 2384 female participants
with data on serum 25(OH)D2 and 25(OH)D3
concentrations measured at 31 years of age (1997),
together with comprehensive measures of daylight,
anthropometric, social, lifestyle and contraceptive
cofactors.
Methods: We assessed a wide range of potential
determinants prior to a nationwide fortification
programme introduced in Finland. The determinants of
25(OH)D2, 25(OH)D3 and 25(OH)D concentrations were
analysed by linear regression and risk factors for being
in lower tertile of 25(OH)D concentration by ordinal
logistic regression.
Results: At the time of sampling, 72% of the
participants were vitamin D sufficient (≥50 nmol/L).
Low sunlight exposure period (vs high) was associated
positively with 25(OH)D2 and negatively with 25(OH)D3
concentrations. Use of oral contraceptives (vs non-
users) was associated with an increase of 0.17 nmol/L
(95% CI 0.08 to 0.27) and 0.48 nmol/L (95% CI 0.41
to 0.56) in 25(OH)D2 and 25(OH)D3 concentrations.
Sex, season, latitude, alcohol consumption and
physical activity were the factors most strongly
associated with 25(OH)D concentration. Risk factors
for low vitamin D status were low sunlight exposure
defined by time of sampling, residing in northern
latitudes, obesity, higher waist circumference, low
physical activity and unhealthy diet.
Conclusions: We demonstrate some differential
associations of environmental and lifestyle factors with
25(OH)D2 and 25(OH)D3 raising important questions
related to personalised healthcare. Future strategies
could implement lifestyle modification and
supplementation to improve vitamin D2 and D3 status,
accounting for seasonal, lifestyle, metabolic and
endocrine status.
INTRODUCTION
Serum 25-hydroxyvitamin D (25(OH)D), the
circulating biomarker of vitamin D status, is
found to be associated with multiple patho-
logical conditions.1–4 There is growing inter-
est in understanding the causal role of
vitamin D in the aetiology of chronic meta-
bolic diseases including obesity,1 2 type 2 dia-
betes3 and mortality.4 Vitamin D is classiﬁed
as a pro-hormone which exists in circulation
Strengths and limitations of this study
▪ Data were from a large homogeneous Northern
Finnish Birth Cohort (latitude ≥65°N) and
included information on several determinants of
25(OH)D2 and 25(OH)D3 in young adults.
▪ The sample was collected in Finland before the
implementation of national policy on fortification
of milk and margarine with vitamin D.
▪ This is the first study to report the influence of
oral contraceptive pills on 25(OH)D2 and 25(OH)
D3 concentrations.
▪ The finding offers an independent replication of
the differential associations of seasonality with
serum 25(OH)D2 and 25(OH)D3 concentrations,
as previously observed in British children sup-
porting evidence for different biological pathways
regulating vitamin D2 and D3 status.
▪ Limitations of the study include lack of a more
precise measure of UV-B exposure, information
on whether study participants were taking
vitamin D supplementation, detailed dietary index
and information on outdoor and indoor physical
activity which could help account for residual
confounders.
Palaniswamy S, et al. BMJ Open 2017;7:e013161. doi:10.1136/bmjopen-2016-013161 1
Open Access Research
 o
n
 12 April 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2016-013161 on 6 March 2017. Downloaded from 
in two major forms of 25(OH)D: 25(OH)D2 (ergocalcif-
erol) and 25(OH)D3 (also known as cholecalciferol).
5 6
Serum 25(OH)D2 is obtained only from plant-derived
dietary sources, fortiﬁcation or supplementation.5 7 In
contrast, 25(OH)D3 is predominantly obtained from
sunlight exposure and smaller quantities from dietary
sources such as fatty ﬁsh, fortiﬁed milk products and
supplements.5 6 In Finland, the milk products and
spreadable fats are fortiﬁed with 25(OH)D3.
8 The
current fortiﬁcation contains 25(OH)D3 due to some-
what lower biopotency of 25(OH)D2 that requests
further understanding.8 Vitamin D status is determined
by measuring 25(OH)D,7 which reﬂects the combined
intake of vitamins 25(OH)D2 and 25(OH)D3 and sub-
cutaneous synthesis during the past 3–4 weeks.5 9 10
There is limited knowledge about the factors asso-
ciated with each isoform that may have differential envir-
onmental determinants.10 Total 25(OH)D and the
relative proportions of 25(OH)D2 and 25(OH)D3 are
suggested to reﬂect a number of health and lifestyle
factors that might be sex speciﬁc.11 12 In young adults,
lifestyle and body composition differ between men and
women.12 13 As to whether the differential composition
of the body between sexes, as well as other endocrine
factors, will be reﬂected by differences in the 25(OH)D
concentration and the 25(OH)D2 and 25(OH)D3 com-
ponents is yet unknown.12 13 There are no previous com-
prehensive studies examining the factors associated with
25(OH)D2 and 25(OH)D3 concentrations in Finland.
This limits the availability of inferences that could help
to identify people at risk of vitamin D deﬁciency, and
improved fortiﬁcation policies to meet the requirements
of those living at northern latitudes.8 14
We examined here factors associated with 25(OH)D2,
25(OH)D3 and total 25(OH)D concentrations in
Finnish adults aged 31 years prior to the implementation
of a nationwide supplementation of vitamin D via fortiﬁ-
cation of milk products and margarine in 2002.8 14
METHODS
Study population
We analysed data on participants from the Northern
Finland Birth Cohort 1966 (NFBC1966) which has previ-
ously been described in detail.15 16 In brief, all women
who were pregnant, residing in Northern Finland (pro-
vinces of Oulu and Lapland) with expected dates of
delivery between 1 January and 31 December,1966 were
targeted for enrolment in the study. Over 96% of eli-
gible women participated. This comprised of 12 055
mothers and 12 058 live born children. The children
were followed up at regular intervals from birth
onwards. In 1997, when participants were aged 31 years,
all cohort participants with known addresses in the pro-
vinces of Oulu and Lapland (65°N to 70°N) and in
Helsinki (60°N) area were sent a postal questionnaire
and invited to a clinical examination which also
included, a fasted blood sample.17 A total of N=4758
individuals of white European origin were included in
the study as shown in online supplementary ﬁgure S1.
All participants gave written informed consent. The pro-
cedures follow the 1964 Helsinki declaration and its
later amendments or comparable ethical standards. The
present study includes individuals with a complete set of
data on variables of interest, as detailed below.
Outcome variables
25(OH)D measurement
Serum 25(OH)D2 and 25(OH)D3 were measured by
liquid chromatography tandem mass spectrometry and
the detailed assay procedure is published elsewhere.18
Participants with 25(OH)D2 values under the detectable
limit were assigned a value of 1.25 nmol/L.18 Total 25
(OH)D is obtained as the actual sum of D2+D3 without
25(OH)D2 low value assignment. Consequently, in the
tables, total 25(OH)D may differ slightly from exact sum
of D2 and D3. Vitamin D sufﬁciency criteria were
deﬁned according to the Institute of Medicine (IOM)
guidelines as ≤30 nmol/L (risk/deﬁciency), 30–
50 nmol/L (risk/insufﬁciency) and ≥50 nmol/L
(sufﬁcient).19
Explanatory factors
The season of participant attendance at the clinical
assessment was categorised according to the Finnish
Meteorological Institute standard as high sunlight
(summer (1 June–30 August) autumn (1 September–31
October)) and low sunlight season (winter
(1 November–31 March) and spring (1 April–31 May)).20
This deﬁnition aims to assess the impact of natural high
and low vitamin D level periods throughout the calendar
year. The residence of the participants at age 31 years was
collected from the population register ofﬁce. They were
categorised as residing in Helsinki (60°N); the city of
Oulu (65°N) and elsewhere in northernmost provinces
of Oulu and Lapland (>65°N). In Helsinki, blood
samples were collected only during winter in contrast to
all year round in other provinces, due to the feasibility of
data collection and were excluded in multivariable ana-
lyses. Height (cm) and weight (kg) were measured in
barefoot and loose clothing by well-trained nurses. Body
Mass Index (BMI) (kg/m2) was calculated and cate-
gorised according to the WHO 1998.21 Waist circumfer-
ence (cm) was categorised as elevated when it was
≥94 cm in men and ≥80 cm in women.22
Categorisation of following lifestyle variables was based
on the responses in the postal questionnaire. Current
smoking was categorised as non-smoker, former/occa-
sional or active smoker. Alcohol consumption during the
6 months prior to the questionnaire was calculated as
grams per day (g/day) and has been described else-
where.23 It was further categorised according to WHO
sex-speciﬁc classiﬁcation as abstainer, low-risk drinker
(≤20 and ≤40 g/day for women and men, respectively)
or at-risk drinker (>20 and >40 g/day for women and
men, respectively).24 The frequency of computer use
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during leisure time was categorised as never, no more
than once per week, on 2–5 days per week or on more
than 5 days per week. The reported frequency and dur-
ation of leisure time and brisk physical activity were used
to calculate the metabolic equivalent of task (MET)
scores in hours per week, and these were ordered into
quartiles. An intensity value of 3 METs is considered as
light physical activity, and 5 METs as brisk physical activ-
ity.25 Diet score was calculated based on the consump-
tion of various food in the previous 6 months and was
reported on a structured six-point scale (from never/
<once per month to several times per day) and has been
described previously.23 The food frequency question
included 32 products categorised under grain products,
milk products, vegetables, meat, fruits and others (cho-
colates, sweets and packaged meals). An unhealthy diet
included daily or frequent consumption of red meat
and less frequent consumption of rye or crisp bread,
berries or fruit, salads and vegetables. The score ranged
from 0–5 and was categorised as healthy diet (<3 points)
and unhealthy diet (4–5 points).23 Current use of
contraception by women was categorised as no contra-
ception use, other methods of contraception (hormone
intrauterine device (IUD), copper IUD, chemical
contraception) or oral contraceptive pill (OCP).26
Socioeconomic position (SEP) was categorised as I and
II (professional), III (skilled worker), IV (unskilled
worker), V (farmer) and VI (others-pensioner, student,
long-term unemployed or not deﬁned). The exclusion
criteria consisted of participants with non-fasting blood
samples, pregnant women, no consent for use of data
and persons whose information was missing on one or
more variables of interest.
Statistical analyses
All statistical analyses were performed using SAS V.9.4
(SAS Institute, Cary, NC, USA). The variables were
assessed for normality and log transformed where rele-
vant. Mean differences between sexes for continuous
variables were measured by independent samples t-test
and analysis of variance; and Pearson χ2 test for categor-
ical variables. We performed univariable linear regres-
sion analysis to explore the association between
explanatory variables and serum 25(OH)D2, 25(OH)D3
and total 25(OH)D concentrations. We log transformed
25(OH)D2, 25(OH)D3 and 25(OH)D, and expressed
these on standardised scales (z-scores). To examine
whether sex was an effect modiﬁer of associations, an
interaction term (sex × explanatory variable) was add-
itionally included in univariable analyses. We conducted
multivariable analyses aiming to examine mutually
adjusted associations of different exposures with 25(OH)
D2, 25(OH)D3 and 25(OH)D measures, namely season
of blood sampling (low and high sunlight period), lati-
tude, BMI, waist circumference, SEP, smoking status,
alcohol consumption, leisure time computer use, phys-
ical activity, diet score and contraception status. In add-
ition, we examined serum 25(OH)D2, 25(OH)D3 and 25
(OH)D concentrations by excluding women using
OCPs.
Following examination of the determinants associated
with 25(OH)D2, 25(OH)D3 and 25(OH)D concentra-
tions, we performed multinomial ordinal logistic regres-
sion analysis to assess the risk factors associated with
being in the lower tertile (reference: tertile III) of
vitamin D. Owing to equivocal deﬁnitions of cut-off
values for vitamin D status in the general population, we
categorised the analysis sample into tertiles of 25(OH)
D. Statistical signiﬁcance was set at global p<0.05 using
two-tailed test.
RESULTS
The characteristics of the study population at age
31 years are summarised in table 1. According to
Institute of Medicine (IOM) criteria for vitamin D sufﬁ-
ciency, 3.3% were deﬁcient, 24.2% were insufﬁcient and
71.5% were sufﬁcient. A total of 3.0% of men and 3.5%
of women were deﬁcient. Serum D2 concentrations were
lower in men when compared with women. However,
the mean serum D3 and total 25(OH)D concentrations
tended to be higher in men than in women, although
the difference was not statistically signiﬁcant. Though,
the difference became more pronounced after exclud-
ing women using OCPs. There were no interactions
observed by sex with any explanatory variables (p for
interactions >0.05, data not shown).
Risk factors associated with lower vitamin D status
according to tertile distribution
Characteristics of the study population across the tertiles
of serum 25(OH)D concentration are summarised in
table 2 (total), online supplementary tables S1 and S2
(men and women, respectively). Unadjusted and
adjusted ordinal logistic regression analyses for the odds
of being in the lower tertiles of 25(OH)D compared with
the highest are shown in online supplementary table S3.
The mutually adjusted model shows the risk of being in
lower tertile of 25(OH)D was increased in individuals
whose blood samples were collected during low sunlight
months, living in higher latitudes, having elevated waist
circumference and unhealthy diet. Figure 1 illustrates
the mutually adjusted analyses with OR estimates for the
impact of daylight, anthropometric, social and lifestyle
risk factors for being in vitamin D tertile I (low) com-
pared with tertile III (high). In sex-stratiﬁed analysis,
women using OCPs had reduced odds of being in the
tertile I (low) of 25(OH)D. The mean vitamin D concen-
tration was ∼10% higher in OCP users (vs non-users).
Factors associated with serum 25(OH)D2, 25(OH)D3 and
25(OH)D concentrations
Univariable and multivariable associations of daylight,
anthropometric, social and lifestyle factors with 25(OH)
D2, 25(OH)D3 and 25(OH)D in the total population are
shown in table 3, online supplementary tables S4 and S5
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Table 1 Characteristics of the study population*
Total Male Female
p ValueSample size (n)
4758 2374 2384
n or
mean
% or
95% CI
n or
mean
% or
95% CI
n or
mean % or 95% CI
Daylight
Season of blood sampling† (n %)
High sunlight 2953 62.1 1501 63.2 1452 60.9 0.09
Low sunlight 1805 37.9 873 36.8 932 39.1
Latitude‡ (n %)
65°N 891 28.7 460 29.3 431 28.1 0.58
>65°N 3105 71.3 1571 70.7 1534 71.9
Anthropometry
BMI (kg/m2) (mean, 95% CI) 24.7 24.6 to 24.8 25.2 25.1 to 25.3 24.1 23.9 to 24.3 <0.01
Waist circumference(cm) (mean, 95% CI) 83.8 83.5 to 84.2 88.9 88.5 to 89.3 78.8 78.3 to 79.2 <0.01
Socioeconomic position: (n %)
I+II (Professional) 1134 23.8 653 27.5 481 20.2 <0.01
III (Skilled worker) 1483 31.2 433 18.2 1050 44.0
IV (Unskilled worker) 1228 25.8 856 36.1 372 15.6
V (Farmer) 165 3.5 111 4.7 54 2.3
VI (Other) 748 15.7 321 13.5 427 17.9
Lifestyle
Smoking (n %)
Non-smoker 2128 44.7 952 40.1 1176 49.4 <0.01
Former/occasional smoker 1214 25.5 600 25.3 614 25.7
Active smoker 1416 29.8 822 34.6 594 24.9
Alcohol consumption (g/day) (n %)
Abstainer 426 8.95 191 8.1 235 9.9 <0.01
Low-risk drinker 4053 85.18 2026 85.3 2027 85.0
At-risk drinker 279 5.86 157 6.6 122 5.1
Leisure time computer use (n %)
Never 1708 35.9 852 35.9 856 35.9 <0.01
No more than once per week 691 14.5 312 13.1 379 15.9
On 2 to 5 days per week 1419 29.8 656 27.6 763 32.0
On more than 5 days per week 940 19.8 554 23.4 386 16.2
Physical activity (MET hours/week)
(mean, 95% CI)
15.0 14.6 to 15.4 14.9 14.4 to 15.6 15.0 14.5 to 15.6 <0.01
Diet score (n %)
0–1 1461 30.71 453 19.1 1008 42.3 <0.01
2–3 2739 57.57 1531 64.5 1208 50.6
4–5 558 11.73 390 16.4 168 7.1
Contraception status§ (n %)
No contraception 1154 49.1
Other kinds of contraception 591 25.1
Oral contraceptive pills (OCP) 607 25.8
Vitamin D status (mean, 95% CI)
Serum total 25(OH)D¶ 68.4 67.6 to 69.2 68.9 67.7 to 70.1 67.9 66.7 to 68.9 0.78
Serum 25(OH)D3 64.8 63.9 to 65.6 65.6 64.4 to 66.7 64.0 62.8 to 65.1 0.45
Serum 25(OH)D2 4.2 3.9 to 4.3 3.9 3.6 to 4.2 4.4 4.1 to 4.7 <0.01
Vitamin D status without OCP** (mean, 95% CI)
Serum total 25(OH)D¶ 67.0 66.2 to 67.9 68.9 67.7 to 70.1 64.6 63.3 to 65.8 <0.01
Serum 25(OH)D3 63.6 62.8 to 64.5 65.6 64.4 to 66.7 60.9 59.8 to 62.2 <0.01
Serum 25(OH)D2 4.0 3.8 to 4.2 3.9 3.6 to 4.2 4.2 3.9 to 4.5 0.05
Values are presented as mean, 95% CIs or number (%).
*p Value was calculated using independent samples t-test for normally distributed variables and Pearson’s χ2 test for categorical variables.
†The season of blood sampling were categorised as high sunlight (summer (1 June–30 August), autumn (1 September–31 October)) and low
sunlight (winter (1 November–31 March) and spring (1 April–31 May)).
‡Data included only on samples taken during all seasons from Oulu city and other provinces of Oulu and Lapland. Data not included on
N=343 in men and N=419 in women with samples taken during winter months from Helsinki region.
§Data available on N=2352 individuals (N=32 missing with contraception status in women).
¶Serum total 25(OH)D may differ slightly from the actual sum of D2 and D3 because of amendment of undetectable D2 values (see
methods).
**Data on N=607 using oral contraceptives excluded.
BMI, body mass index; MET, metabolic equivalent of task of physical activity; 25(OH)D, 25-hydroxyvitamin D; 25(OH)D2, ergocalciferol; 25
(OH)D3, cholecalciferol.
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Table 2 The characteristic of all Northern Finland Birth Cohort (NFBC) 1966 participants (N=4758) in the present study at 31 years
by serum 25-hydroxyvitamin D tertiles* (I= the lowest tertile; III= the highest tertile)
I II III
Tertile of serum 25(OH)D†
N
1592 1589 1577
n or mean % or 95% CI n or mean % or 95% CI n or mean % or 95% CI p Value
Sex n %
Males 782 32.9 800 33.7 792 33.4 0.75
Females 810 33.9 789 33.2 785 32.9
Environmental factors
Season of blood drawn‡ n %
High sunlight 566 19.2 1012 34.3 1375 46.5 <0.0001
Low sunlight 1026 56.9 577 31.9 202 11.2
Latitude§ n %
65°N 210 23.6 305 34.2 376 42.2 0.0006
>65°N 923 29.7 1042 33.6 1140 36.7
Anthropometry
Body mass index (kg/m2) mean 95% CI 24.8 24.6 to 25.0 24.8 24.6 to 24.9 24.4 24.2 to 24.6 0.017
Waist circumference (cm) mean 95% CI 84.6 83.9 to 85.2 84.0 83.4 to 84.6 82.9 82.3 to 83.4 0.0003
Socioeconomic position n %
I+II (Professional) 421 37.2 374 32.9 339 29.9 0.0046
III (Skilled worker) 501 33.8 503 33.9 479 32.3
IV (Unskilled worker) 386 31.4 427 34.8 415 33.8
V (Farmer) 60 36.4 49 29.7 56 33.9
VI (Other) 224 29.9 236 31.6 288 38.5
Lifestyle factors
Smoking n %
Non-smoker 742 34.9 686 32.2 700 32.9 0.055
Former/occasional smoker 366 30.2 438 36.1 410 33.7
Active smoker 484 34.2 465 32.9 467 32.9
Alcohol consumption (g/day) n %
Abstainer 165 38.7 146 34.3 115 27.0 0.053
Low risk drinker 1335 32.9 1349 33.3 1369 33.8
At-risk drinker 92 32.9 94 33.7 93 33.4
Leisure time computer use n %
Never 537 31.4 599 35.1 572 33.5 0.0012
No more than once per week 208 30.1 234 33.9 249 36.0
On 2 to 5 days per week 487 34.3 447 31.5 485 34.2
On more than 5 days per week 360 38.3 309 32.9 271 28.8
Quartile of physical activity (MET hours per week) n %
QI: 0.0–3.79 444 36.6 394 32.5 376 30.9 <0.0001
QII: 3.80–11.29 403 33.9 421 35.4 365 30.7
QIII: 11.30–21.99 415 34.5 397 33.0 391 32.5
QIV: >22.0 330 28.7 377 32.7 445 38.6
Diet score n %
0–1 478 32.7 477 32.7 506 34.6 0.26
2–3 912 33.3 920 33.6 907 33.1
4–5 202 36.2 192 34.4 164 29.4
Females only
Contraception n %
No contraception 441 38.2 401 34.8 312 27.0 <0.001
Other kinds of contraception 216 36.6 187 31.6 188 31.8
Oral contraceptive pills 140 23.1 190 31.3 277 45.6
The values are expressed as mean and 95% CIs; numbers and %.
*Differences between males and females were tested with ANOVA for normally distributed variables and Pearson’s χ2 test for categorical
variables.
†Mean (95% CI) of 25-hydroxyvitamin D tertiles for all were 41.50 (41.11 to 41.89), 63.87 (63.55 to 64.19) and 100.01 (98.81 to 101.22).
Serum total 25(OH)D may differ slightly from the actual sum of D2 and D3 because of amendment of undetectable D2 values (see methods).
‡The season of blood sampling were categorised as high sunlight (summer (1 June–30 August), autumn (1 September–31 October)) and low
sunlight (winter (1 November–31 March) and spring (1 April–31 May)).
§Data included only on samples taken during all seasons from Oulu city and other provinces of Oulu and Lapland. Data not included on
N=343 in men and N=419 in women with samples taken during winter months from Helsinki region.
MET, metabolic equivalent of task of physical activity; 25(OH)D, 25-hydroxyvitamin D;
Palaniswamy S, et al. BMJ Open 2017;7:e013161. doi:10.1136/bmjopen-2016-013161 5
Open Access
 o
n
 12 April 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2016-013161 on 6 March 2017. Downloaded from 
(men and women, respectively). The factors associated
with 25(OH)D2 and 25(OH)D3 were sex, season of
blood sampling, latitude, obesity, waist circumference
and physical activity. Unhealthy diet and active smoking
were univariably associated with lower 25(OH)D2 con-
centrations; and SEP was associated univariably with
lower 25(OH)D3 concentrations.
In multivariable analyses, sex was associated with
serum 25(OH)D2 and 25(OH)D3 concentrations. Men
had 0.5 nmol/L lower 25(OH)D2 but 1.6 nmol/L
higher 25(OH)D3 than women. When women using
oral contraceptives were excluded from the analysis, the
association between sex and 25(OH)D2 concentration
was attenuated (β=0.06; 95% CI −0.002 to 0.13).
Conversely, the sex difference still persisted for 25(OH)
D3 concentrations (β=−0.21; 95% CI −0.26 to −0.15),
that is, women having lower concentrations. Low sun-
light exposure period (vs high) at sampling associated
with higher concentrations of 25(OH)D2 but lower con-
centrations of 25(OH)D3. Alcohol abstainers were asso-
ciated with lower 25(OH)D3 concentrations than any
other level of drinker. In addition, unhealthy diet score
and leisure time computer use were associated with
lower 25(OH)D3 concentrations.
In sex-stratiﬁed analyses, the associations were in the
same direction and of similar magnitude with 25(OH)
D2 and 25(OH)D3 concentrations. Female OCP users
(vs non-users) had greater serum 25(OH)D2 and 25
Figure 1 Forest plots showing the risk factors associated with low vitamin D status based on tertile distribution in the total
population and by sex. Associations from mutually adjusted ordinal logistic regression ORs (on log scale) show the risk of being
in the lower vitamin D tertile.
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Table 3 Major factors associated with serum 25(OH)D2 (vitamin D2), 25(OH)D3 (vitamin D3) and total 25(OH)D (vitamin D) nmol/L concentrations assessed by univariable and
multiple linear regression analysis, total (N=4758)*
Explanatory
variables
Serum 25(OH)D2, nmol/L† Serum 25(OH)D3, nmol/L† Serum 25(OH)D, nmol/L†
Univariable Multivariable‡ Univariable Multivariable‡ Univariable Multivariable‡
Β 95% CI β 95% CI β 95% CI β 95% CI β 95% CI β 95% CI
Sex (reference: males)
Females 0.10 0.04 to 0.16 0.12 0.06 to 0.18 −0.06 −0.12 to −0.003 −0.09 −0.14 to −0.04 −0.04 −0.09 to 0.02 −0.06 −0.12 to −0.01
Global p value 0.0008 0.0001 0.038 0.0005 0.21 0.019
Daylight
Season of blood sampling § (reference: high sunlight)
Low sunlight 0.57 0.51 to 0.63 0.29 0.21 to 0.36 −1.03 −1.08 to −0.98 −0.43 −0.49 to −0.36 −0.92 −0.97 to −0.87 −0.36 −0.42 to −0.29
Global p value <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001
Latitude (reference: 65°N)
>65°N −0.08 −0.16 to −0.01 −0.06 −0.13 to 0.02 −0.14 −0.21 to −0.07 −0.18 −0.24 to −0.12 −0.16 −0.23 to −0.08 −0.20 −0.26 to −0.13
Global p value 0.023 0.12 0.0002 <0.0001 <0.0001 <0.0001
Anthropometry
BMI (kg/m2) (reference : normal (18.5–24.99))
Underweight
(<18.5)
−0.05 −0.25 to 0.15 −0.06 −0.24 to 0.13 −0.08 −0.27 to 0.12 −0.06 −0.22 to 0.10 −0.09 −0.29 to 0.11 −0.08 −0.25 to 0.09
Overweight
(25–29.99)
−0.10 −0.17 to −0.04 −0.01 −0.08 to 0.06 0.02 −0.04 to 0.08 −0.001 −0.06 to 0.06 −0.004 −0.07 to 0.06 −0.005 −0.07 to 0.06
Obese (≥30) −0.13 −0.24 to −0.03 −0.01 −0.14 to 0.11 −0.19 −0.30 to −0.09 −0.16 −0.27 to −0.06 −0.23 −0.33 to −0.12 −0.17 −0.27 to −0.06
Global p value 0.0035 0.94 0.0008 0.0035 0.0002 0.0057
Waist circumference (cm) (reference: m<94, f<80)
M≥94, F≥80 −0.09 −0.15 to −0.03 −0.10 −0.18 to −0.02 −0.13 −0.19 to −0.07 −0.05 −0.12 to 0.01 −0.15 −0.21 to −0.09 −0.08 −0.15 to −0.01
Global p value 0.003 0.013 <0.0001 0.11 <0.0001 0.030
Socioeconomic position (reference: I+II (professional))
III (Skilled worker) −0.05 −0.13 to 0.03 −0.05 −0.13 to 0.02 0.08 0.001 to 0.15 0.03 −0.04 to 0.09 0.07 −0.003 to 0.15 0.03 −0.04 to 0.09
IV (Unskilled
worker)
−0.06 −0.15 to 0.02 0.01 −0.07 to 0.10 0.14 0.06 to 0.22 0.02 −0.05 to 0.09 0.12 0.04 to 0.21 0.03 −0.05 to 0.10
V(Farmer) −0.11 −0.27 to 0.06 −0.02 −0.18 to 0.14 0.06 −0.10 to 0.22 −0.06 −0.19 to 0.08 0.03 −0.13 to 0.20 −0.06 −0.20 to 0.08
VI(Other) −0.14 −0.23 to −0.05 −0.06 −0.16 to 0.03 0.21 0.11 to 0.29 0.05 −0.03 to 0.13 0.18 0.09 to 0.28 0.05 −0.03 to 0.13
Global p value 0.056 0.33 0.0002 0.49 0.0012 0.56
Lifestyle
Smoking (reference: non-smoker)
Former/
occasional
smoker
−0.03 −0.10 to 0.04 −0.01 −0.08 to 0.06 0.05 −0.02 to 0.12 0.02 −0.03 to 0.08 0.04 −0.03 to 0.11 0.02 −0.04 to 0.08
Active smoker −0.10 −0.17 to −0.03 −0.05 −0.12 to 0.02 0.007 −0.06 to 0.07 −0.05 −0.10 to 0.01 −0.02 −0.08 to 0.05 −0.06 −0.12 to 0.0002
Global p value 0.014 0.37 0.39 0.071 0.37 0.051
Alcohol consumption (g/day) (reference: abstainer)
Low risk drinker 0.04 −0.06 to 0.14 0.07 −0.03 to 0.16 0.17 0.07 to 0.27 0.12 0.04 to 0.20 0.19 0.09 to 0.29 0.14 0.06 to 0.23
At-risk drinker 0.03 −0.12 to 0.18 0.07 −0.08 to 0.21 0.13 −0.02 to 0.28 0.19 0.06 to 0.31 0.14 −0.02 to 0.29 0.20 0.07 to 0.33
Global p value 0.71 0.39 0.0043 0.0041 0.0012 0.0019
Continued
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Table 3 Continued
Explanatory
variables
Serum 25(OH)D2, nmol/L† Serum 25(OH)D3, nmol/L† Serum 25(OH)D, nmol/L†
Univariable Multivariable‡ Univariable Multivariable‡ Univariable Multivariable‡
Β 95% CI β 95% CI β 95% CI β 95% CI β 95% CI β 95% CI
Leisure time computer use (reference : never)
No more than
once per week
0.03 −0.06 to 0.12 0.002 −0.08 to 0.09 0.01 −0.08 to 0.09 0.02 −0.05 to 0.09 0.01 −0.08 to 0.10 0.02 −0.06 to 0.09
On 2 to 5 days
per week
0.03 −0.04 to 0.10 −0.01 −0.08 to 0.06 −0.04 −0.11 to 0.03 −0.03 −0.09 to 0.03 −0.03 −0.10 to 0.04 −0.03 −0.09 to 0.03
On more than
5 days per week
0.09 0.01 to 0.17 0.02 −0.07 to 0.10 −0.20 −0.28 to −0.12 −0.09 −0.16 to −0.02 −0.17 −0.25 to −0.10 −0.08 −0.15 to −0.01
Global p value 0.14 0.93 <0.0001 0.026 <0.0001 0.10
Quartile of physical activity (MET-hours per week) (reference: QI: 0.0–3.79)
QII: 3.80–11.29 0.08 0.0003 to 0.16 0.05 −0.03 to 0.12 −0.02 −0.10 to 0.06 0.003 −0.06 to 0.07 −0.01 −0.09 to 0.07 0.01 −0.06 to 0.07
QIII: 11.30–21.99 0.10 0.02 to 0.18 0.05 −0.03 to 0.12 0.02 −0.06 to 0.10 0.05 −0.01 to 0.12 0.04 −0.04 to 0.12 0.07 −0.002 to 0.13
QIV: >22.0 0.11 0.03 to 0.20 0.08 −0.002 to 0.16 0.15 0.07 to 0.23 0.14 0.07 to 0.20 0.18 0.10 to 0.26 0.16 0.09 to 0.23
Global p value 0.022 0.29 <0.0001 <0.0001 <0.0001 <0.0001
Diet score (reference: healthy diet)
Unhealthy diet −0.12 −0.21 to −0.03 −0.06 −0.15 to 0.02 −0.07 −0.15 to 0.02 −0.07 −0.15 to
−0.0004
−0.10 −0.18 to −0.01 −0.09 −0.17 to −0.01
Global p value 0.009 0.14 0.15 0.049 0.034 0.022
*The values are standardised regression coefficients (β) and p values from linear regression models by entering each variable separately in univariable analysis and by entering all the variables
in multivariable analysis.
†1 SD increase/decrease in 25(OH)D2, 25(OH)D3 and 25(OH)D nmol/L per 1 unit or category change in explanatory variable.
‡Analysis performed on N=3996 (total). Blood drawn only in winter on N=343 men and N=419 in women residing in Helsinki were excluded.
§The season of blood sampling were categorised as high sunlight (summer (1 June–30 August), autumn (1 September–31 October)) and low sunlight (winter (1 November–31 March) and
spring (1 April–31 May)).
MET, metabolic equivalent of task of physical activity; 25(OH)D, 25-hydroxyvitamin D; 25(OH)D2, ergocalciferol; 25(OH)D3, cholecalciferol.
8
Palanisw
am
y
S,etal.BM
J
Open
2017;7:e013161.doi:10.1136/bm
jopen-2016-013161
O
p
e
n
A
c
c
e
s
s
 on 12 April 2019 by guest. Protected by copyright. http://bmjopen.bmj.com/ BMJ Open: first published as 10.1136/bmjopen-2016-013161 on 6 March 2017. Downloaded from 
(OH)D3 concentrations of 0.17 nmol/L and 0.48 nmol/
L, respectively.
Total 25(OH)D associations with potential determi-
nants reﬂect similar associations as reported for 25(OH)
D3 concentrations, with the exception of waist circumfer-
ence and leisure time computer use (table 3). OCP
users (vs non-users) were associated with a 0.50 nmol/L
greater serum 25(OH)D concentration.
DISCUSSION
According to the present data collected in 1997, 28% of
young adults in Northern Finland were exposed to the
risk of vitamin D insufﬁciency deﬁned by IOM. The
average vitamin D status observed in our study was
higher than those reported by other studies from the
same geographical location (ie, Finland,27 28), despite
these latter samples being collected after 2002, that is,
year of the ﬁrst Finnish fortiﬁcation campaign for
vitamin D. The mean concentration of serum 25(OH)D
measured in both precited studies of the same geo-
graphical location (mean age: approx. 37 and 60 years)
were nearly 10 nmol/L lower when compared with our
population. Our present sample can be considered as a
good representation of the young adult population
living in Finland at the time of measurement.29 In com-
parison with previous ﬁndings, our data may also raise
queries about the efﬁcacy of the ﬁrst wave of fortiﬁcation
introduced in Finland in the year 2002.8 The fortiﬁca-
tion levels were since increased in 2010.8 Careful consid-
eration should be made before speculating a potential
causation. We must acknowledge, for instance, the differ-
ences in study design such as analysis of wider age
groups and determination of vitamin D status by radio-
immunoassay as opposed to mass spectrometry.
Adding to previous literature, we observed a strong
impact of the duration of sunlight in determining the
vitamin D status irrespective of the gender.27 30 31 The
latitude of residence also plays an important role in
determining vitamin D status. During the six long winter
months in northern latitudes (>60°N), the few hours of
daylight are incapable of increasing vitamin D naturally.6
The usage of computers outside working hours and a
reduced level of physical activity were negatively asso-
ciated with vitamin D status, which supports previous
reports.30–33 It is suspected that the observed association
between the characteristics of sedentary behaviour in
young adults and a lower vitamin D status is likely to be
explained by signiﬁcant changes in the time spent out-
doors.30 32 33 Unfortunately, the current study does not
distinguish between indoor and outdoor physical activity
that would help to ascertain this hypothesis. In addition,
our results supported the negative association between
vitamin D status and obesity or higher waist circumfer-
ence.1 27 32 33 The current hypotheses linking obesity
and reduced vitamin D status consider either an effect
due to an increased capacity of storage of vitamin D in
the fat tissue or the interplay with autocrine factors
produced by the adipose tissues.2 34 The experimental
evidence from animal and human studies is suggesting a
direct biological pathway, although the question of
reverse causality has not been fully addressed.1 2
Currently, the epidemiological data in adults is support-
ing a causal inference of increased BMI in the reduction
of vitamin D status while the reverse has not been con-
ﬁrmed.1 In addition, unhealthy diet was negatively asso-
ciated with vitamin D status. Unfortunately, the food
questionnaire used in the present study could not dis-
criminate precisely the consumption of fatty ﬁsh or
mushrooms to account for a precise dietary quantity of
vitamin D3 and D2, respectively. Diet score has been pre-
viously examined in the same sample as an adequate
proxy of a healthy or unhealthy diet,23 but future
research with precise food frequency questionnaire is
warranted. This will help understand the role of the
natural source of dietary vitamin D to reinforce mainten-
ance of a healthy dietary intake whenever possible.
Many reports and reviews consider vitamin D status as
a mere representation of individual lifestyle and health
behaviour.35 The positive association between vitamin D
status and the use of OCP is in contrast with the sugges-
tion that vitamin D status merely bio-marks a healthy
status. In fact, OCP was linked to 10% higher vitamin D
status as consistently reported.36 37 Similarly, one study
which examined the effect of hormonal contraceptives
during vitamin D supplementation in premenopausal
women reported that the use of exogenous oestrogen
would enhance the response to supplementation.38 It is
not apparent what the underlying mechanism is pertain-
ing to a higher vitamin D status in women using OCP.
Two hypotheses are currently being examined to under-
stand such association. These examine whether the
mechanisms by which oestrogen increases the 25(OH)D
are due to higher activity of vitamin D 25-hydroxylase in
the liver,39 or an increase in circulating concentration of
vitamin D binding protein (DBP).37 According to the
IOM classiﬁcation, OCP users in our study are more
likely to be classiﬁed as vitamin D sufﬁcient. Previous
research using the same data has shown a link between
the use of OCP and inﬂammation.26 It will therefore be
essential to analyse the pathways underpinning the role
of OCP in simultaneously increasing inﬂammation and
vitamin D status. Based on evidence from this and other
studies reporting consistently higher vitamin D status in
women using OCP, it may be important to implement a
corrective factor to the IOM criteria to avoid overesti-
mation of vitamin D status in this subgroup of women.
Importance of considering D3 and D2 isoforms
Public health recommendations and clinical diagnostics
do not currently distinguish between vitamin D2 and
D3.10 However, there is disagreement on whether these
two forms should be considered equivalent.10 40
Additionally, 25(OH)D3 accounted for the vast majority
(>90%) of the circulating 25(OH)D concentrations in
the present population. Our study and the study
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performed by Tolppanen et al31 were in agreement on
the reported associations between the season of blood
sampling and the concentrations in 25(OH)D2 and 25
(OH)D3. The determinants associated with the vitamin
D status also inﬂuenced the serum concentrations of 25
(OH)D3, with the highest effect being exerted by the
season. Importantly, we replicated the associations of the
seasonal variation but not the SEP as ﬁrst observed in
children (mean age 9.8 years) of the Avon Longitudinal
Studies of Parents and Children.31 As expected, 25(OH)
D3, known as the main contributor of vitamin D status
obtained from sunlight, was positively associated with the
season of blood sampling and latitude of residence.
Interestingly, we observed a heightened vitamin 25(OH)
D2 status during the winter months that has yet to be
understood. However, we do not have information on
supplement use which hinders the ability to assess the
increased vitamin 25(OH)D2 status during winter. As
suggested by Tolppanen and colleagues, if serum
vitamin D2 is largely associated with dietary and some
socioeconomic related factors, this may provide an indi-
cation of compensatory behaviour which can be
adopted to correct the vitamin D status during the low
sunlight months.31
CONCLUSIONS AND IMPLICATIONS
Our results have provided information on the potential
determinants associated with the vitamin D status prior
to the implementation of a nationwide fortiﬁcation
policy. Understanding the associations between sex,
season, latitude and multiple lifestyle factors with dual
sources of vitamin D (25(OH)D2 and 25(OH)D3) will
help better understand the role of vitamin D in research,
clinical and public health implications. The data also
supported a differential association of 25(OH)D2 and 25
(OH)D3 concentrations with sunlight which might have
an impact on future strategy for supplementation. These
differential results also question current strategies of
vitamin D supplementation and IOM cutoffs for vitamin
D sufﬁciency and warrant a personalised approach,
accounting for individual and lifestyle characteristics.
The fortiﬁcation of ﬂuid milk products (0.5 μg/100 g)
was introduced in Finland in 2002 with limited efﬁciency
in all age groups.8 More recently, in April 2010, the forti-
ﬁcation levels have been raised further (1.0 μg/100 g).8
In addition, in 2012, the Nordic and Finnish nutritional
experts have recommended 10 μg/day for all individuals
aged 6 months to 75 years, in addition to dietary
intake.41 Our intended follow-up study from NFBC1966
at 46 years,42 will be helpful in measuring the efﬁciency
of waves of fortiﬁcation before (1997) and after (2012),
taking into account multiple determinants and personal
supplement use in Northern Finland.
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